The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

Sanofi reports amlitelimab improved lung function in asthma, with new phase 3 trials planned across its respiratory pipeline.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD: Paris Wednesday, April 16, 2025, 10:00 Hrs [IST] Sanofi shared new pro ...

Please provide your email address to receive an email when new articles are posted on . Several European studies have investigated integrating spirometry at the time of low-dose CT. Spirometry ...

Long-term ICS use in COPD increases risks of severe health conditions like Type 2 diabetes and fractures. Read more!

Addressing the burden of patients living with chronic disease, Pfizer built on its pipeline of innovative hemophilia therapies, while Verona’s dual-action treatment for COPD offers a ...

Cardiopulmonary risk has recently been proposed and is defined as: The risk of serious and/or cardiovascular events in ...